25.20
-0.95
(-3.63%)
At close: January 24 at 4:48:30 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
45,491.00
45,491.00
58,690.00
33,317.00
68,268.00
Investing Cash Flow
-22,926.00
-22,926.00
-15,277.00
-11,921.00
-19,336.00
Financing Cash Flow
-198,413.00
-198,413.00
-27,577.00
-21,995.00
-21,522.00
End Cash Position
72,016.00
72,016.00
249,660.00
234,082.00
234,313.00
Capital Expenditure
-18,025.00
-18,025.00
-18,591.00
-20,418.00
-20,701.00
Issuance of Debt
19.00
19.00
22.00
3.00
22.00
Repayment of Debt
-1,047.00
-1,047.00
-963.00
-1,171.00
-1,254.00
Repurchase of Capital Stock
-122.00
-122.00
-6,362.00
-12.00
-4.00
Free Cash Flow
27,466.00
27,466.00
40,099.00
12,899.00
47,567.00
12/31/2020 - 9/13/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
526075.BO 526075.BO,0P0000BXCE,0
4.5000
0.00%
TRA.VN Traphaco Joint Stock Company
76,900.00
0.00%
AX9.SG Akebia Therapeutics Inc
2.2580
-0.88%
6CQ.BE Cresco Labs Inc
0.8830
+4.07%
R9U2.F Green Thumb Industries Inc.
6.67
-0.67%
AX9.F Akebia Therapeutics, Inc.
2.2020
-1.87%
RAPH Raphael Pharmaceutical Inc.
1.0000
0.00%
NECLIFE.BO Nectar Lifesciences Limited
36.65
-4.98%
STSN Stemsation International, Inc.
0.0060
-33.33%
APPH.DE Apontis Pharma AG
10.40
+1.96%